These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8489562)

  • 1. Effect of naftidrofuryl on platelet-induced vasospasm in vitro. Role of antiserotonergic actions.
    Verheggen R; Schrör K
    Arzneimittelforschung; 1993 Mar; 43(3):330-4. PubMed ID: 8489562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
    Verheggen R; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S264-7. PubMed ID: 3248112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
    Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
    Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K; Murata S; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets, eicosanoids, and coronary vasospasm.
    Schrör K; Verheggen R
    Prog Clin Biol Res; 1987; 242():165-70. PubMed ID: 3118379
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory mechanisms of action of K+ channel openers on contraction induced by an agonist in canine coronary arterial smooth muscle.
    Yanagisawa T; Yamagishi T; Taira N
    Jpn J Pharmacol; 1992; 58 Suppl 2():332P. PubMed ID: 1507581
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein reduces agonist-induced contractions of porcine coronary arterial smooth muscle in a cyclic AMP-dependent manner.
    Lee MY; Leung SW; Vanhoutte PM; Man RY
    Eur J Pharmacol; 2004 Oct; 503(1-3):165-72. PubMed ID: 15496311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human platelets and leukocytes in modulation of vascular tone.
    Kaul S; Waack BJ; Padgett RC; Brooks RM; Heistad DD
    Am J Physiol; 1994 May; 266(5 Pt 2):H1706-14. PubMed ID: 8203570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system.
    Banerjee AK; Tuffin DP; Walker JL
    Br J Pharmacol; 1985 Jan; 84(1):71-80. PubMed ID: 3884073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different sensitivity of basilar and saphenous arteries to thromboxane A2-induced contractions. Effect of imidazole 2-hydroxybenzoate (ITF 182).
    Pagella PG; Agozzino S; Bellavite O; Donà GC; Mendola N
    Arzneimittelforschung; 1984; 34(11):1514-6. PubMed ID: 6596952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can we inhibit 5-HT-induced platelet aggregation and why should we bother?
    Heptinstall S; Bevan J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):475-8. PubMed ID: 2465956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naftidrofuryl inhibits contractions to serotonin in intact and de-endothelialized cerebral arteries in vitro.
    Oudart N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S45-8. PubMed ID: 1369718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane.
    Blaise GA; Parent M; Laurin S; Omri A; Reader TA; Moutquin JM
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):175-81. PubMed ID: 8204810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
    Wiernsperger NF
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet prostanoids in interaction of platelets with collagen substrates. II. Effects of exogenous arachidonic acid, stable PG endoperoxides analogue, and aspirin.
    Mazurov AV; Leytin VL; Repin VS; Taube C; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S373-6. PubMed ID: 6440553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the spasmogenic effect of exogenous and endogenous serotonin on isolated blood vessels by naftidrofuryl].
    Verheggen R; Schrör K
    Vasa Suppl; 1988; 24():5-10. PubMed ID: 3212604
    [No Abstract]   [Full Text] [Related]  

  • 18. Insurmountable antagonism of AT-1015, a 5-HT2 antagonist, on serotonin-induced endothelium-dependent relaxation in porcine coronary artery.
    Rashid M; Nakazawa M; Nagatomo T
    J Pharm Pharmacol; 2003 Jun; 55(6):827-32. PubMed ID: 12841944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery.
    Kawasaki J; Kobayashi S; Miyagi Y; Nishimura J; Fujishima M; Kanaide H
    Br J Pharmacol; 1997 Jul; 121(5):977-85. PubMed ID: 9222556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
    Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
    Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.